BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6100180)

  • 1. Circulating and urinary cAMP levels in chronic and acute myeloid leukemia.
    Singh RP; Chansouria JP; Singh JN; Singh VP; Udupa KN
    Indian J Cancer; 1984; 21(4):122-5. PubMed ID: 6100180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary elimination of beta aminoisobutyric acid in malignant hemopathies].
    Roulaud F; Boisseau M; Moreau F; Labatut M
    C R Seances Soc Biol Fil; 1971; 165(1):83-7. PubMed ID: 4257756
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
    Nielsen HR; Killmann SA
    J Natl Cancer Inst; 1983 Nov; 71(5):887-91. PubMed ID: 6580488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the isoenzymic patterns of urinary ribonucleases in healthy subjects and patients with chronic granulocytic leukemia.
    Naskalski J
    Pol Med J; 1972; 11(4):827-34. PubMed ID: 4507414
    [No Abstract]   [Full Text] [Related]  

  • 5. [New protein abnormity in urine in myeloic leukemias].
    Ledderose G; Tischendorf FW; Wilmanns W; Tischendorf MM
    Verh Dtsch Ges Inn Med; 1973; 79():387-9. PubMed ID: 4524461
    [No Abstract]   [Full Text] [Related]  

  • 6. Preparation of colony stimulating activity from human leukemic urine: hydrophobic chromatography on propylamine-agarose.
    Barresi R; Bianchi Scarrà GL; Ravazzolo R; Sessarego M
    Biomedicine; 1980; 33(6):178-81. PubMed ID: 6971130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus-like particles and cytopathic activity in urine of patients with leukemia.
    Ames RP; Sobota JT; Reagan RL; Karon M
    Blood; 1966 Sep; 28(3):465-78. PubMed ID: 5223201
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mycologic studies in the course of acute and chronic myeloid leukemia].
    Sobótka S
    Pol Tyg Lek; 1967 Oct; 22(45):1743-4. PubMed ID: 5234738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical findings in body fluids in leukemia patients. Changes in the urine].
    Ledvina M
    Z Gesamte Inn Med; 1967 Jul; 22(14):409-15. PubMed ID: 4233203
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous bone marrow transplantation in relapsed acute leukemias and chronic myeloid leukemia in blast crisis.
    Izzi T; Moretti L; Polchi P; Galimberti M; Delfini C; Porcellini A; Lucarelli G
    Haematologica; 1983; 68(3):368-80. PubMed ID: 6411531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemical analysis of a supernatant of a leukemic cell culture].
    Kiersnowska-Rogowska B
    Pol Tyg Lek; 1981 Apr; 36(15):533-4. PubMed ID: 6269101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Platelet-like bodies in urine of patients with leukaemia (author's transl)].
    Kono N; Toyama K; Chen TP; Suzawa N; Mizokami T
    Nihon Hinyokika Gakkai Zasshi; 1978 Apr; 69(4):443-7. PubMed ID: 276646
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
    Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
    Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biochemical studies of the supernatant of leukemia cell cultures].
    Kiersnowska-Rogowska B
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():21-52. PubMed ID: 6101032
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lysozymuria - a regular characteristic of PAS-positive myeloid leukemia].
    Ledderose G; Tischendorf FW; Wilms K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1103-5. PubMed ID: 274023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lysozymuria in leukemias].
    Jaworkovsky L; Grant H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(4):358-76. PubMed ID: 4132190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunoglobulin levels and complement system activity in leukemia].
    Kiersnowska-Rogowska B; Pietruska Z; Hryszko S; Bielawiec M
    Pol Tyg Lek; 1981 Feb; 36(6):213-6. PubMed ID: 6945567
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with the treatment of acute leukemias and blast crises in chronic myeloproliferative diseases].
    Eggeling T; Braumann D; Mainzer K
    Med Welt; 1981 Jul; 32(27):1077-80. PubMed ID: 6943405
    [No Abstract]   [Full Text] [Related]  

  • 20. Sister chromatid exchange and growth kinetics in chronic myeloid leukemia.
    Stoll C; Oberling F; Roth MP
    Cancer Res; 1982 Aug; 42(8):3240-3. PubMed ID: 6953996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.